Show simple item record

dc.contributor.authorSurendranathan, Ajenthanen
dc.contributor.authorO'Brien, Johnen
dc.date.accessioned2018-06-06T14:09:39Z
dc.date.available2018-06-06T14:09:39Z
dc.date.issued2018-05en
dc.identifier.issn1362-0347
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/276672
dc.description.abstractDementia with Lewy bodies(DLB) is a common neurodegenerative dementia in older people, however, the clinical features particularly cognitive fluctuations and REM sleep disorder are often hard to elicit, leading to difficulty in making the diagnosis clinically. Here we examine the literature for the evidence behind imaging modalities that could assist in making the diagnosis. Dopamine transporter(DAT) imaging remains the best modality for differentiation from dementia of Alzheimer’s type with high sensitivity and specificity reported based on pathological diagnoses. 123Iodine- metaiodobenzylguanidine myocardial scintigraphy (MIBG) however is rapidly becoming an alternative imaging modality for the diagnosis of DLB, though studies assessing its accuracy with post-mortem verification are still awaited. However, there are suggestions that MIBG may be better in the differentiation of vascular parkinsonism from DLB, than DAT scans, but may have lower sensitivity for detecting DLB compared to the 80% sensitivity seen in DAT imaging. Structural MRI scans have long been used for the diagnosis of dementia, however their utility in DLB is limited to revealing the presence of co-existing Alzheimer’s disease. Fluorodeoxyglucose (FDG) PET is an alternative biomarker that can also differentiate Alzheimer’s disease and DLB, but lacks the evidence base of both DAT and MIBG scans.
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.publisherBMJ
dc.subjectHumansen
dc.subjectLewy Body Diseaseen
dc.subjectPositron-Emission Tomographyen
dc.subjectTomography, Emission-Computed, Single-Photonen
dc.subjectMagnetic Resonance Imagingen
dc.subjectMyocardial Perfusion Imagingen
dc.titleClinical imaging in dementia with Lewy bodies.en
dc.typeArticle
prism.endingPage65
prism.issueIdentifier2en
prism.publicationDate2018en
prism.publicationNameEvidence-based mental healthen
prism.startingPage61
prism.volume21en
dc.identifier.doi10.17863/CAM.23967
dcterms.dateAccepted2018-03-06en
rioxxterms.versionofrecord10.1136/eb-2017-102848en
rioxxterms.versionAM*
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2018-05en
dc.contributor.orcidSurendranathan, Ajenthan [0000-0003-3809-1545]
dc.contributor.orcidO'Brien, John [0000-0002-0837-5080]
dc.identifier.eissn1468-960X
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idCambridge University Hospitals NHS Foundation Trust (CUH) (146281)
rioxxterms.freetoread.startdate2019-03-29


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record